Expertise in
10
conditions

Hiroyuki G. Tanaka

Kurashiki, JP 
Expertise in
10
conditions
Kurashiki, JP 

Overview

Hiroyuki Tanaka practices practicing medicine in Kurashiki, Japan.

Mr. Tanaka is highly rated in 10 conditions, according to our data. His clinical expertise encompasses X-Linked Hypophosphatemia, Hypophosphatemia, Rickets, Thrombectomy, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 62 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Kurashiki, Japan
Other Locations
Okayama, Japan
Tokyo, Japan
Higashi-onoda, 7560884, Japan
Fukuoka, Japan
Minato, 1088639, Japan
Hongo, 1130033, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Drug, Biological
Study Phase: Phase 3
A Phase 3, Open-Label, Randomized, Multicenter, 12-month, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin® Therapy in Japanese Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-Label, Randomized, Multicenter, 12-month, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin® Therapy in Japanese Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

62 Total Publications

Short-Term Outcomes of Cardiogenic Shock Treated With a Microaxial Flow Pump.
Short-Term Outcomes of Cardiogenic Shock Treated With a Microaxial Flow Pump.
Journal: JACC. Asia
Published: July 01, 2025

Frequently Asked Questions about Hiroyuki G. Tanaka

Is Hiroyuki G. Tanaka a top-rated expert for X-Linked Hypophosphatemia?

MediFind is an objective health platform that identifies experts based on real-world data. Hiroyuki G. Tanaka is classified as an Distinguished expert for X-Linked Hypophosphatemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hiroyuki G. Tanaka participate in research or clinical trials?

Yes. Hiroyuki G. Tanaka has published 62 articles and abstracts on conditions like X-Linked Hypophosphatemia. You can view a list of Hiroyuki G. Tanaka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tanaka's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile